Mobidiag

Mobidiag is a Finnish biotechnology company that specializes in developing and providing innovative molecular diagnostic solutions for infectious diseases. The company was founded in 2000 and has since become a leading player in the field of rapid and multiplexed diagnostics.

Mobidiag's primary focus is on developing and commercializing molecular diagnostics tests for detecting and identifying various pathogens, including bacteria, viruses, and parasites. Their solutions are designed to provide rapid and accurate results, enabling healthcare professionals to make informed treatment decisions more quickly.

One of Mobidiag's notable products is the Amplidiag® platform, which consists of a range of diagnostic tests and instruments. The Amplidiag platform utilizes real-time polymerase chain reaction (PCR) technology to detect and identify multiple pathogens simultaneously from a single patient sample. This multiplexing capability allows for efficient and comprehensive testing, particularly in the context of infectious disease outbreaks.

Mobidiag's molecular diagnostic solutions have been used in the detection and management of various infectious diseases, including gastrointestinal infections, respiratory tract infections, and antibiotic-resistant bacteria. Their technologies offer the potential for faster and more accurate diagnosis, leading to improved patient care and better antimicrobial stewardship.

Headquarters: Helsinki: Espoo

Founded: 2000

Website: https://mobidiag.com/